secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2022-08-08T23:59:59+00:00
Accession:  0001193125-22-215003
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight files $200M shelf registration and enters $50M ATM equity offering with BofA
--------------------------------------------------------------------------------

- Filed $200M shelf registration on Form S-3 covering common stock, preferred, debt, warrants, and units.
- Entered ATM agreement to sell up to $50M of common stock through BofA Securities.
- Registration statement is not yet effective; no sales can occur until SEC declares it effective.
- BofA will receive 3% commission on gross proceeds from ATM sales; Company may also sell directly to BofA as principal.
- Either party may terminate the ATM agreement with three days' written notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000119312522215003/0001193125-22-215003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000119312522215003/d388777d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-215003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer